Literature DB >> 24242296

Large molecule specific assay operation: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Lauren Stevenson1, Marian Kelley, Boris Gorovits, Clare Kingsley, Heather Myler, Karolina Osterlund, Arumugam Muruganandam, Yoshiyuki Minamide, Mario Dominguez.   

Abstract

The L2 Global Harmonization Team on large molecule specific assay operation for protein bioanalysis in support of pharmacokinetics focused on the following topics: setting up a balanced validation design, specificity testing, selectivity testing, dilutional linearity, hook effect, parallelism, and testing of robustness and ruggedness. The team additionally considered the impact of lipemia, hemolysis, and the presence of endogenous analyte on selectivity assessments as well as the occurrence of hook effect in study samples when no hook effect had been observed during pre-study validation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24242296      PMCID: PMC3889533          DOI: 10.1208/s12248-013-9542-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  16 in total

1.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

2.  2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections.

Authors:  Fabio Garofolo; Mario L Rocci; Isabelle Dumont; Suzanne Martinez; Steve Lowes; Eric Woolf; Peter van Amsterdam; Surendra Bansal; Ariadna Cristina Gomes Barra; Ronald Bauer; Brian P Booth; Montserrat Carrasco-Triguero; Binodh DeSilva; John Dunn; Keith Gallicano; Dominique Gouty; Stacy Ho; Richard Hucker; Mohammed Jemal; Noriko Katori; Olivier Le Blaye; Jean Lee; Wenkui Li; Steve Michael; Corey Nehls; Robert Nicholson; Eric Ormsby; Daniel Tang; C T Viswanathan; Russell Weiner; Graeme Young
Journal:  Bioanalysis       Date:  2011-09       Impact factor: 2.681

3.  Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins.

Authors:  Jean Lee; Hongjin Ma
Journal:  AAPS J       Date:  2007-05-25       Impact factor: 4.009

4.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

Review 5.  Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development.

Authors:  Jean W Lee; Marian Kelley; Lindsay E King; Jihong Yang; Hossein Salimi-Moosavi; Meina T Tang; Jian-Feng Lu; John Kamerud; Ago Ahene; Heather Myler; Cindy Rogers
Journal:  AAPS J       Date:  2011-01-15       Impact factor: 4.009

6.  A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect.

Authors:  Ching-Hua Lu; Bernadett Kalmar; Andrea Malaspina; Linda Greensmith; Axel Petzold
Journal:  J Neurosci Methods       Date:  2010-12-04       Impact factor: 2.390

7.  Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.

Authors:  Thomas R Kozel; Randall S MacGill; Ann Percival; Qing Zhou
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Interferences in immunoassay.

Authors:  Jill Tate; Greg Ward
Journal:  Clin Biochem Rev       Date:  2004-05

9.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388

10.  Prozone in malaria rapid diagnostics tests: how many cases are missed?

Authors:  Philippe Gillet; Annelies Scheirlinck; Jocelijn Stokx; Anja De Weggheleire; Hélder S Chaúque; Oreana D J V Canhanga; Benvindo T Tadeu; Carla D D Mosse; Armindo Tiago; Samuel Mabunda; Cathrien Bruggeman; Emmanuel Bottieau; Jan Jacobs
Journal:  Malar J       Date:  2011-06-15       Impact factor: 2.979

View more
  4 in total

Review 1.  Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Authors:  Darshana Jani; John Allinson; Flora Berisha; Kyra J Cowan; Viswanath Devanarayan; Carol Gleason; Andreas Jeromin; Steve Keller; Masood U Khan; Bill Nowatzke; Paul Rhyne; Laurie Stephen
Journal:  AAPS J       Date:  2015-09-16       Impact factor: 4.009

2.  Calculations for Adjusting Endogenous Biomarker Levels During Analytical Recovery Assessments for Ligand-Binding Assay Bioanalytical Method Validation.

Authors:  John F Marcelletti; Cindy L Evans; Manju Saxena; Adriana E Lopez
Journal:  AAPS J       Date:  2015-04-23       Impact factor: 4.009

3.  Introduction to the proposals from the global bioanalysis consortium harmonization team.

Authors:  Philip Timmerman; Mark Arnold; Binodh DeSilva; Fabio Garofolo; Michaela Golob; Peter van Amsterdam; Shinobu Kudoh; Puran Singhal; Daniel Tang; Maria Francesca Riccio; Rafael Barrientos; Shrinivas Savale; Tatsuo Kurokawa
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

4.  Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.

Authors:  Ching-Hua Lu; Axel Petzold; Jo Topping; Kezia Allen; Corrie Macdonald-Wallis; Jan Clarke; Neil Pearce; Jens Kuhle; Gavin Giovannoni; Pietro Fratta; Katie Sidle; Mark Fish; Richard Orrell; Robin Howard; Linda Greensmith; Andrea Malaspina
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-09       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.